The Perceived Impact of COVID-19 on the Mental Health Status of Adolescent and Young Adult Survivors of Childhood Cancer and the Development of a Knowledge Translation Tool to Support Their Information Needs.

COVID-19 adolescent and young adult cancer mental health pediatric oncology psychosocial oncology survivors of childhood cancer

Journal

Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902

Informations de publication

Date de publication:
2022
Historique:
received: 31 01 2022
accepted: 28 04 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Adolescent and young adult (AYA; 13 to 39 years) survivors of childhood cancer may be especially vulnerable to physical health and mental health concerns during the pandemic. We investigated the impact of COVID-19 on the mental health status of AYA survivors (Aim 1) and shared tailored, evidence-based health-related information on COVID-19 (Aim 2). Between May and June 2020, participants completed a cross-sectional online survey assessing their cancer history, current mental health status, and their COVID-19 information needs. Ninety-four participants (78 females, 13 males, 2 non-binary) with a mean age of 26.9 years (SD = 6.2) were included in the final sample. Participants reported residing from 10 countries and 94% identified as White. Nearly half of the participants (49%) described their mental health status as worse now than before the pandemic. Thirty-nine participants (41%) that indicated their current mental health status was tied to fears/worries about their past cancer and treatment experienced a higher level of anxiety and PTSS than those who did not report the same. Most participants (77%) had not received any information related to the potential risks of COVID-19 and expressed an interest in receiving this information. In response, an infographic detailing recommended strategies for coping with mental health problems in the pandemic, along with preliminary study findings, was developed. AYA survivors reporting their mental health status was linked to their past cancer experienced poorer mental health. There is a value to educating survivors on their potential health risks, but accounting for their perceived mental health vulnerabilities should be considered when disseminating knowledge. The use of an infographic is a unique contribution towards the development of innovative and personalized means of sharing health education to this vulnerable yet resilient group. This research on the mental health status of AYA survivors very early in the pandemic informs continued initiatives investigating the rapidly changing nature of how COVID-19 may impact AYA survivors today and in the future.

Sections du résumé

Background UNASSIGNED
Adolescent and young adult (AYA; 13 to 39 years) survivors of childhood cancer may be especially vulnerable to physical health and mental health concerns during the pandemic. We investigated the impact of COVID-19 on the mental health status of AYA survivors (Aim 1) and shared tailored, evidence-based health-related information on COVID-19 (Aim 2).
Methods UNASSIGNED
Between May and June 2020, participants completed a cross-sectional online survey assessing their cancer history, current mental health status, and their COVID-19 information needs.
Results UNASSIGNED
Ninety-four participants (78 females, 13 males, 2 non-binary) with a mean age of 26.9 years (SD = 6.2) were included in the final sample. Participants reported residing from 10 countries and 94% identified as White. Nearly half of the participants (49%) described their mental health status as worse now than before the pandemic. Thirty-nine participants (41%) that indicated their current mental health status was tied to fears/worries about their past cancer and treatment experienced a higher level of anxiety and PTSS than those who did not report the same. Most participants (77%) had not received any information related to the potential risks of COVID-19 and expressed an interest in receiving this information. In response, an infographic detailing recommended strategies for coping with mental health problems in the pandemic, along with preliminary study findings, was developed.
Discussion UNASSIGNED
AYA survivors reporting their mental health status was linked to their past cancer experienced poorer mental health. There is a value to educating survivors on their potential health risks, but accounting for their perceived mental health vulnerabilities should be considered when disseminating knowledge. The use of an infographic is a unique contribution towards the development of innovative and personalized means of sharing health education to this vulnerable yet resilient group. This research on the mental health status of AYA survivors very early in the pandemic informs continued initiatives investigating the rapidly changing nature of how COVID-19 may impact AYA survivors today and in the future.

Identifiants

pubmed: 35846688
doi: 10.3389/fpsyg.2022.867151
pmc: PMC9285488
doi:

Types de publication

Journal Article

Langues

eng

Pagination

867151

Informations de copyright

Copyright © 2022 Hou, Tran, Cho, Forbes, Forster, Stokoe, Allapitan, Wakefield, Wiener, Heathcote, Michel, Patterson, Reynolds and Schulte.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Adolesc Health. 2020 Nov;67(5):714-717
pubmed: 33099414
JAMA Netw Open. 2018 Jun 1;1(2):e180350
pubmed: 30646082
Cancer. 2018 May 1;124(9):2045-2057
pubmed: 29468664
BMJ. 2017 Aug 2;358:j3453
pubmed: 28768629
JAMA. 2002 Apr 10;287(14):1832-9
pubmed: 11939869
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
JCO Clin Cancer Inform. 2018 Dec;2:1-15
pubmed: 30652583
J Adolesc Young Adult Oncol. 2021 Oct 1;:
pubmed: 34597190
JCO Oncol Pract. 2021 Sep;17(9):e1258-e1269
pubmed: 33492984
J Cancer Surviv. 2021 Jun 14;:
pubmed: 34125379
Pediatr Blood Cancer. 2013 Mar;60(3):402-8
pubmed: 22829446
Int J Ment Health Nurs. 2020 Jun;29(3):315-318
pubmed: 32277578
JAMA Pediatr. 2016 May 1;170(5):495-501
pubmed: 26999630
J Adolesc. 2021 Feb;87:15-27
pubmed: 33450464
QJM. 2020 May 1;113(5):311-312
pubmed: 32227218
Cancer. 2020 Oct 1;126(19):4414-4422
pubmed: 32697342
J Clin Oncol. 2018 Jul 10;36(20):2088-2100
pubmed: 29775389
Int J Environ Res Public Health. 2020 Nov 16;17(22):
pubmed: 33207689
CA Cancer J Clin. 2014 Mar-Apr;64(2):83-103
pubmed: 24488779
Psychiatry Res. 2021 Sep;303:114074
pubmed: 34271372
Int J Antimicrob Agents. 2020 Apr;55(4):105946
pubmed: 32199877
J Epidemiol Community Health. 2010 Apr;64(4):284-91
pubmed: 19692738
J Clin Oncol. 2018 Jul 20;36(21):2190-2197
pubmed: 29874134
Lancet Oncol. 2017 Jun;18(6):719-731
pubmed: 28410997
Nat Rev Cancer. 2014 Jan;14(1):61-70
pubmed: 24304873
Transl Psychiatry. 2020 Jul 31;10(1):263
pubmed: 32737292
Support Care Cancer. 2021 Jan;29(1):17-19
pubmed: 33052443
Cancer. 2021 Apr 15;127(8):1325-1333
pubmed: 33332603
Pediatr Clin North Am. 2020 Dec;67(6):1083-1101
pubmed: 33131536
Int J Cancer. 2012 Mar 1;130(5):1145-50
pubmed: 21445977
Health Policy. 2004 Aug;69(2):169-78
pubmed: 15212864
J Clin Oncol. 1998 Aug;16(8):2864-7
pubmed: 9704740
Pediatr Blood Cancer. 2004 Feb;42(2):161-8
pubmed: 14752881
Oncologist. 2020 Feb;25(2):e351-e372
pubmed: 32043786
J Clin Endocrinol Metab. 2006 Nov;91(11):4401-7
pubmed: 16954158
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
J Clin Child Adolesc Psychol. 2018 Jan-Feb;47(1):38-46
pubmed: 28820616
Eur J Cancer. 2008 Sep;44(14):2074-85
pubmed: 18674895
Psychooncology. 2016 Nov;25(11):1308-1316
pubmed: 26403252
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Qual Health Res. 2022 Feb;32(3):426-439
pubmed: 35068285
Pediatr Blood Cancer. 2020 Dec;67(12):e28715
pubmed: 32970366
Clin Child Psychol Psychiatry. 2022 Jan;27(1):201-213
pubmed: 34865537
Pediatr Blood Cancer. 2015 Dec;62 Suppl 5:S514-84
pubmed: 26700918
Pediatr Blood Cancer. 2021 Apr;68(4):e28943
pubmed: 33565259

Auteurs

Sharon H J Hou (SHJ)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Psychology, British Columbia Children's Hospital, Vancouver, BC, Canada.

Andrew Tran (A)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Sara Cho (S)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Caitlin Forbes (C)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Victoria J Forster (VJ)

The Hospital for Sick Children, Toronto, ON, Canada.

Mehak Stokoe (M)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Elleine Allapitan (E)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Claire E Wakefield (CE)

School of Women's and Children's Health, UNSW Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.

Lori Wiener (L)

Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.

Lauren C Heathcote (LC)

Health Psychology Section, Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Gisela Michel (G)

Department Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.

Pandora Patterson (P)

Research, Evaluation and Policy Unit, Canteen Australia, Sydney, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Kathleen Reynolds (K)

Long Term Survivor's Clinic, Alberta Children's Hospital, Calgary, AB, Canada.
Department of Medicine, Faculty of Family Medicine, University of Calgary, Calgary, AB, Canada.

Fiona S M Schulte (FSM)

Department of Oncology, Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Long Term Survivor's Clinic, Alberta Children's Hospital, Calgary, AB, Canada.

Classifications MeSH